Literature DB >> 27803500

Issues Surrounding Testosterone Replacement Therapy.

Carson Schlich, Frank Romanelli.   

Abstract

Testosterone is derived from Leydig cells and exerts its effects on androgen receptors to influence growth, mood, voice, and several other bodily functions. As men age, their testosterone levels decline. Human immunodeficiency virus (HIV) infection has also been associated with lowered serum testosterone levels. Subtherapeutic levels of testosterone may lead to fatigue, loss of libido, and dysphoria. Exogenous replacement of testosterone can be accomplished by several modalities (oral, topical, injection), with each having distinct advantages and disadvantages. Even though testosterone replacement has become a popular medical intervention, recent reports have made the practice increasingly controversial. Several small retrospective investigations have recently associated testosterone replacement with an increased risk of cardiovascular complications. Replacement should be used sparingly until further conclusive data regarding the efficacy and safety of testosterone become available.

Entities:  

Keywords:  hormones; hypogonadism; steroids; testosterone

Year:  2016        PMID: 27803500      PMCID: PMC5080989          DOI: 10.1310/hpj5109-712

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  19 in total

Review 1.  Counteracting muscle wasting in HIV-infected individuals.

Authors:  W D Dudgeon; K D Phillips; J A Carson; R B Brewer; J L Durstine; G A Hand
Journal:  HIV Med       Date:  2006-07       Impact factor: 3.180

2.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors:  Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-11       Impact factor: 6.053

Review 3.  Update in testosterone therapy for men.

Authors:  Giovanni Corona; Giulia Rastrelli; Gianni Forti; Mario Maggi
Journal:  J Sex Med       Date:  2011-03       Impact factor: 3.802

Review 4.  Clinical review: Why is androgen replacement in males controversial?

Authors:  Glenn R Cunningham; Shivani M Toma
Journal:  J Clin Endocrinol Metab       Date:  2010-09-29       Impact factor: 5.958

5.  Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.

Authors:  Jacques Baillargeon; Randall J Urban; Abraham Morgentaler; Charles J Glueck; Gwen Baillargeon; Gulshan Sharma; Yong-Fang Kuo
Journal:  Mayo Clin Proc       Date:  2015-07-20       Impact factor: 7.616

Review 6.  A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management.

Authors:  Nancy F Crum; Kari J Furtek; Patrick E Olson; Christopher L Amling; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2005-10       Impact factor: 5.078

Review 7.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Eric L Ding; Yiqing Song; Vasanti S Malik; Simin Liu
Journal:  JAMA       Date:  2006-03-15       Impact factor: 56.272

Review 8.  Topical testosterone supplementation for the treatment of male hypogonadism.

Authors:  Katrina A Abadilla; Adrian S Dobs
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

9.  Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.

Authors:  Robert M Coward; Jay Simhan; Culley C Carson
Journal:  BJU Int       Date:  2008-12-23       Impact factor: 5.588

10.  Premature decline of serum total testosterone in HIV-infected men in the HAART-era.

Authors:  Vincenzo Rochira; Lucia Zirilli; Gabriella Orlando; Daniele Santi; Giulia Brigante; Chiara Diazzi; Federica Carli; Cesare Carani; Giovanni Guaraldi
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

View more
  1 in total

Review 1.  End-of-Life Care and Bereavement Issues in Human Immunodeficiency Virus-AIDS.

Authors:  Karl Goodkin; Sindhura Kompella; Steven F Kendell
Journal:  Nurs Clin North Am       Date:  2018-03       Impact factor: 1.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.